GSK plc GSK
NYSE GSK
$50.32 -0.09 (-0.18%)
At close: Nov 6, 2026 · 4:00 PM EST

Gsk (GSK) Property, Plant & Equipment (Net) (2009 - 2026)

Updated

Gsk (GSK) posted Property, Plant & Equipment (Net) of $12.48 billion for the quarter ended Sep 30, 2026, down 0.6% from $12.55 billion a year earlier but up 0.6% from the prior quarter.

Analysis

Gsk (GSK) Property, Plant & Equipment (Net) (2009 - 2026) Analysis & Trends

As of Dec 31, 2025, Gsk's Property, Plant & Equipment (Net) came in at $12.55 billion, up 8.4% from the prior year.

  • Annual Property, Plant & Equipment (Net) has increased for three consecutive years, though with a five-year compound annual growth rate of -2.0% (years ended Dec 2020 to Dec 2025).
  • In prior years, Gsk's Property, Plant & Equipment (Net) was $11.58 billion in the year ended Dec 31, 2024 (+0.8%), $11.49 billion in the year ended Dec 31, 2023 (+6.6%), $10.77 billion in the year ended Dec 31, 2022 (-19.7%) and $13.41 billion in the year ended Dec 31, 2021 (-3.3%).
  • Quarterly Property, Plant & Equipment (Net) has run from a low of $2.09 billion in the quarter ended Mar 31, 2022 to a high of $13.41 billion in the quarter ended Dec 31, 2021 over five years.
  • On a year-over-year basis, Property, Plant & Equipment (Net) increased in six of the last eight quarters, with growth averaging 4.0%.
  • The strongest year-over-year quarter for Property, Plant & Equipment (Net) in the past five years was the quarter ended Mar 31, 2023, with growth of 420.3%; the weakest was the quarter ended Mar 31, 2022, with a decline of 84.6%.
  • According to Business Quant data, Property, Plant & Equipment (Net) for the three prior quarters was $12.4 billion (quarter ended Jun 30, 2026), $12.3 billion (quarter ended Mar 31, 2026) and $12.55 billion (quarter ended Dec 31, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn 32.19 Bn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 24.10 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn 5.94 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn 25.90 Bn
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn 14.06 Bn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn 8.88 Bn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn 5.95 Bn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn 19.05 Bn
10 Gsk 102.08 Bn 84.92 Bn 8.73 Bn 12.48 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 12.48 Bn
Jun 30, 2026 12.40 Bn
Mar 31, 2026 12.30 Bn
Dec 31, 2025 12.55 Bn
Sep 30, 2025 12.55 Bn
Jun 30, 2025 12.51 Bn
Mar 31, 2025 11.84 Bn
Dec 31, 2024 11.58 Bn
Sep 30, 2024 11.89 Bn
Jun 30, 2024 11.36 Bn
Mar 31, 2024 11.30 Bn
Dec 31, 2023 11.49 Bn
Sep 30, 2023 10.76 Bn
Jun 30, 2023 10.93 Bn
Mar 31, 2023 10.85 Bn
Dec 31, 2022 10.77 Bn
Sep 30, 2022 9.94 Bn
Jun 30, 2022 10.32 Bn
Mar 31, 2022 2.09 Bn
Dec 31, 2021 13.41 Bn
API Access

Gsk Property, Plant & Equipment (Net) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=property-plant-and-equipment-net&ticker=GSK&period=max&api_key=YOUR_API_KEY